Tenderwize
Back to tender search

Open house pharmaceutical discount agreements for active substance Biperiden, ATC N04AA02

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Biperiden, ATC N04AA02

45/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

45 / 100

Complexity

30 / 100

Risk factors

The buyer reserves the right to replace open-house agreements with exclusive discount contracts, which would automatica...

No estimated volume or value; discount rates are not specified but must be agreed upon. The actual profitability depend...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of authorized and marketable pharmaceutical products containing Biperiden (ATC N04AA02).
  • Agreement to offer discount on the drug's price as per SGB V §§130a(8)/130c(1).
Show full summary

This is an open-house model for non-exclusive pharmaceutical discount agreements on the active substance Biperiden (ATC N04AA02) with AOK Rheinland-Pfalz/Saarland. The contract is not a public procurement under EU directives but published voluntarily for transparency. The procedure allows any interested pharmaceutical company to enter into a standard agreement at any time during a 24-month window (June 2025 – May 2027), with uniform conditions. No estimated value is provided. The buyer reserves the right to replace these agreements with exclusive ones through separate tenders, which would automatically terminate open-house contracts.

Risks

The buyer reserves the right to replace open-house agreements with exclusive discount contracts, which would automatica...

No estimated volume or value; discount rates are not specified but must be agreed upon. The actual profitability depend...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Products must be authorized and marketable in Germany (verified via Lauer-Taxe or AMIce database).

Administrative

  • Submission of signed contract documents and supporting evidence of drug authorization/marketability.
  • No electronic submission allowed; documents must be submitted in original.

Buyer

Lots (1)

LOT-0001

Open house pharmaceutical discount agreements for active substance Biperiden, ATC N04AA02

Non-exclusive discount agreements for Biperiden products. All interested pharmaceutical companies can join under uniform terms. Maximum contract duration 24 months. First possible start date: 01.06.2025. Contracts can be terminated by the buyer early if exclusive agreements are concluded.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
235451-2025

Documents (1)

Similar tenders